- Filed
- Feb 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 4, 2026 | 117.29M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 122.88M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 117.05M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 116.21M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 118.01M sh |
| Stock Repurchased | Q3 2026 · Dec 31, 2025 | $253.23K |
| Stock Repurchased | Q3 2026 · Dec 31, 2024 | $541.72K |
| Capex | Q3 2026 · Dec 31, 2025 | $2.24M |
| Capex restated | Q3 2026 · Dec 31, 2024 | $2.59M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $69.86M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $30.23M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $237.27M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $235.42M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $222.51M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $222.03M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $299.62M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $325.57M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $342.49M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | $358.05M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $20.65M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $62.09M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $34.39M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $75.3M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $82.52M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $72.15M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $271.65M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $297.33M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.04 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.23 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.47 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.04 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.23 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.47 |
| Net Income | Q3 2026 · Dec 31, 2025 | $2.23M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$2.82M |
| Net Income | Q3 2026 · Sep 30, 2025 | $1.4M |
| Net Income | Q3 2026 · Jun 30, 2025 | −$6.46M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$26.13M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$53.32M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$12.43M |
| Net Income | Q3 2026 · Jun 30, 2024 | −$14.76M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $1.97M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$3.34M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$20.51M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$32.77M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $11.66M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $32.44M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $10.95M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $31.9M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $1.73M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $4.8M |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $1.57M |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $4.89M |
| Revenue | Q3 2026 · Dec 31, 2025 | $13.39M |
| Revenue | Q3 2026 · Dec 31, 2025 | $37.24M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $12.52M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $36.79M |